Rhodia streamlines paracetamol business. (News).(Brief Article)

Chemical Market Reporter, August, 2003

RHODIA IS improving its competitive position in analgesics by reinforcing its more cost-effective manufacturing operations. The company is making a major investment in its Wuxi, China, paracetamol (acetaminophen or APAP) production facility and consolidating its North American and European operations.

Rhodia will shutter its Luling, La., paracetamol operations in 2004 and consolidate production in Roussillon, France, and Wuxi. Following these changes, paracetamol production capacity will be adjusted to match current levels. In a "several million dollar investment," the Wuxi facility will gain new units for direct compression paracetamol products, which should be completed this summer," says a Rhodia spokesperson. Existing units for powder grade...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.